BPMC Stock Price History and Quote Analysis: Insights for Investors
Blueprint Medicines Corporation
Stock Price Today
Blueprint Medicines Corporation (BPMC) stock declined over -1.86%, trading at $84.82 on NASDAQ, down from the previous close of $86.43. The stock opened at $86.30, fluctuating between $84.56 and $86.76 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 638 |
| Beta | 0.58 |
| Sales or Revenue | $249.38M |
| 5Y Sales Change% | 3.058% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Blueprint Medicines Corporation (NASDAQ: BPMC) stock price is $84.82 in the last trading session. During the trading session, BPMC stock reached the peak price of $86.76 while $84.56 was the lowest point it dropped to. The percentage change in BPMC stock occurred in the recent session was -1.86% while the dollar amount for the price change in BPMC stock was -$1.61.
The NASDAQ listed BPMC is part of Biotechnology industry that operates in the broader Healthcare sector. Blueprint Medicines Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Debra Durso-Bumpus
Chief People Officer
Dr. Percy H. Carter M.B.A., Ph.D.
Chief Scientific Officer
Jenna Cohen
Senior Director & Head of Investor Relations
Mr. Michael Landsittel
Chief Financial Officer
Mr. Alexis A. Borisy A.M.
Founder & Executive Chairman of Board of Directors
Ms. Tracey L. McCain Esq.
Executive Vice President, Chief Legal & Compliance Officer and Sec.
Mr. Jeffrey W. Albers J.D., M.B.A., MBA
Executive Chairman
Ms. Christina Rossi
Chief Operating Officer
Dr. Christopher K. Murray
Senior Vice President of Technical Operations
Dr. Christopher K. Murray Ph.D.
Senior Vice President of Technical Operations and Chief Technical Operations & Quality Officer
Ms. Ariel Hurley
Senior Vice President, Fin. & Principal Accounting Officer
Ms. Kathryn Haviland
Pres, Chief Executive Officer & Director
BPMC's closing price is 96.92% higher than its 52-week low of $43.89 where as its distance from 52-week high of $121.90 is -29.1%.
Number of BPMC employees currently stands at 638.
Official Website of BPMC is: https://www.blueprintmedicines.com
BPMC could be contacted at phone 617 374 7580 and can also be accessed through its website. BPMC operates from 45 Sidney Street, Cambridge, MA 02139, United States.
BPMC stock volume for the day was 265.52K shares. The average number of BPMC shares traded daily for last 3 months was 677.5K.
The market value of BPMC currently stands at $5.37B with its latest stock price at $84.82 and 63.35M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com